Newstalk
Newstalk

08.16 19 Mar 2018


Share this article


Doctors may soon be able to spare some cancer patients the harsh effects of chemotherapy, according to new research funded by the Irish Cancer Society (ICS).

Researchers from the ICS cancer research centre 'Breast-Predict' have developed a tool which may predict how effective chemotherapy is likely to be in treating triple-negative breast cancer patients.

More than 250 people are diagnosed with triple-negative breast cancer each year in Ireland.

This form of breast cancer is often aggressive, difficult to treat and tends to be more common in younger women.

For chemotherapy to work, it has to kill cancer cells in the body.

Researchers at Royal College Surgeons in Ireland (RCSI) in Dublin have identified a mathematical formula on cells with triple negative breast cancer to predict how effective chemotherapy would be in killing them.

By using their formula in the lab, the research team now predicts that triple negative breast cancer cells may respond to a new drug - already being used to treat some leukaemia patients.

Their study showed that BCL2 inhibitors can enhance the response of cancer cells to chemotherapy.

Dr Robert O'Connor, head of cancer research at the Irish Cancer Society, said: "This paper highlights vital work being undertaken to identify new ways to improve the treatment of cancer.

"This research is in quite early stages and it will be many more years until any potential benefits reach cancer patients.

"But it does show the building blocks required to lay the foundations for life-saving cancer research.

"The more we understand this disease, the better chance we have of stopping it in its tracks".

He added: "The Irish Cancer Society can only invest in vital research because of the public's generous support.

"We currently fund more than 100 researchers across Ireland and have spent €25m on life-saving cancer research since 2010.

"To continue doing this, we need everyone to get involved in Daffodil Day on Friday, March 23rd. Your support saves lives."

This early stage research was led by Irish Cancer Society-funded PhD student Federico Lucantoni, under the supervision of Jochen Prehn, Professor of Physiology and director of the RCSI’s Centre for Systems Medicine.


Share this article


Read more about

News

Most Popular

Live: Title

Now playing

00:00:00 / 00:00:00
Added to queue
Removed from queue

On Air

Share

Share


Up next

Episode title
Show
Duration

You currently have no podcasts in your queue.

Go to podcasts

On Air

DOCUMENTARY AND DRAMA ON NEWST...

DOCUMENTARY AND DRAMA ON NEWSTALK

21:00-22:00

Share

Up next

YOU COULDN'T MAKE IT UP.

YOU COULDN'T MAKE IT UP.

22:00-22:30

Share

THE HARD SHOULDER

THE HARD SHOULDER

22:30-23:30

Share

FUTUREPROOF

FUTUREPROOF

23:30-00:00

Share

FUTUREPROOF

FUTUREPROOF

00:00-00:15

Share

BEST OF NEWSTALK

BEST OF NEWSTALK

00:15-07:00

Share

DOCUMENTARY AND DRAMA ON NEWST...

DOCUMENTARY AND DRAMA ON NEWSTALK

07:00-08:00

Share

BETWEEN THE LINES

BETWEEN THE LINES

08:00-09:00

Share

BOBBY'S LATE BREAKFAST

BOBBY'S LATE BREAKFAST

09:00-11:00

Share

ON THE RECORD

ON THE RECORD

11:00-13:00

Share

OFF THE BALL

OFF THE BALL

13:00-18:00

Share

TECH TALK

TECH TALK

18:00-19:00

Share

TALKING HISTORY

TALKING HISTORY

19:00-20:00

Share

TALKING BOOKS

TALKING BOOKS

20:00-21:00

Share

UNDER THE COVERS

UNDER THE COVERS

21:00-22:00

Share

00:00:00 / 00:00:00

Share on